Our results show NGS is a highly sensitive and specific method for primary SMA screening, with 100% sensitivity and specificity in detecting the homozygous SMN1 exon 7 deletion in over 2500 samples with a sample failure rate of 0%. The gene discussed is SMN1; the disease is proximal spinal muscular atrophy.